Shopping Cart
Remove All
Your shopping cart is currently empty
Zanidatamab (ZW25) is a humanised bispecific monoclonal antibody that simultaneously targets two distinct HER2 epitopes located on ECD2 and ECD4, thereby enhancing receptor clustering and signaling blockade, Zanidatamab exhibits strong anti-tumour activity, supporting its application in HER2-positive cancer research and antibody-based therapeutic development.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $356 | - | In Stock | |
| 5 mg | $937 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,490 | 2-4 weeks | 2-4 weeks |
| Description | Zanidatamab (ZW25) is a humanised bispecific monoclonal antibody that simultaneously targets two distinct HER2 epitopes located on ECD2 and ECD4, thereby enhancing receptor clustering and signaling blockade, Zanidatamab exhibits strong anti-tumour activity, supporting its application in HER2-positive cancer research and antibody-based therapeutic development. |
| Targets&IC50 | HER2:0.9-16 nM (KD) |
| Synonyms | ZW-25, ZW25, ZW 25 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | ECD2/ECD4 |
| Cas No. | 2169946-15-8 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.